- Home
- CERS vs MCR Comparison
CERS vs MCR Comparison
Compare CERS & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- MCR
- Stock Information
- Founded
- CERS 1991
- MCR 1989
- Country
- CERS United States
- MCR United States
- Employees
- CERS N/A
- MCR N/A
- Industry
- CERS EDP Services
- MCR Trusts Except Educational Religious and Charitable
- Sector
- CERS Technology
- MCR Finance
- Exchange
- CERS Nasdaq
- MCR Nasdaq
- Market Cap
- CERS 324.3M
- MCR 268.5M
- IPO Year
- CERS 1997
- MCR N/A
- Fundamental
- Price
- CERS $1.58
- MCR $6.20
- Analyst Decision
- CERS Buy
- MCR
- Analyst Count
- CERS 3
- MCR 0
- Target Price
- CERS $3.17
- MCR N/A
- AVG Volume (30 Days)
- CERS 1.2M
- MCR 66.7K
- Earning Date
- CERS 10-30-2024
- MCR 01-01-0001
- Dividend Yield
- CERS N/A
- MCR 8.52%
- EPS Growth
- CERS N/A
- MCR N/A
- EPS
- CERS N/A
- MCR 0.38
- Revenue
- CERS $176,229,000.00
- MCR N/A
- Revenue This Year
- CERS $26.47
- MCR N/A
- Revenue Next Year
- CERS $11.48
- MCR N/A
- P/E Ratio
- CERS N/A
- MCR $16.61
- Revenue Growth
- CERS 14.71
- MCR N/A
- 52 Week Low
- CERS $1.38
- MCR $5.63
- 52 Week High
- CERS $2.59
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- CERS 38.88
- MCR 33.08
- Support Level
- CERS $1.53
- MCR $6.17
- Resistance Level
- CERS $1.83
- MCR $6.40
- Average True Range (ATR)
- CERS 0.11
- MCR 0.04
- MACD
- CERS -0.03
- MCR -0.02
- Stochastic Oscillator
- CERS 13.89
- MCR 4.00
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.